I can answer the 1st question and I have zero contact with anyone a cvbt. The stock is not relisting this year. Common sense should tell us that unless trials have been completed and there is a product ready for market a relisting of the stock at $3 dollars would be a fire sale and the price would quickly become a dime. Then try to move the company forward with the stock diluted and devalued.
not relisting this year and not concerned
I do hope there is some announcement concerning trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.